The development of new drugs for rare diseases is a challenging process due to small patient populations and the high cost of clinical trials. One key challenge is identifying optimal dosing regimens. Pharmacokinetics of drugs can vary widely between individuals, and it can be difficult to obtain enough data from clinical trials to make informed decisions about dosing.

This webinar discusses the challenges and opportunities of developing drugs for rare diseases and how population pharmacokinetic (PPK) modeling can be used to identify optimal dosing regimens for new drug candidates. The also discusses the advantages of using a medical communications and publications writing team to accelerate the process of publishing drug development research.